NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
0.110
+0.005 (4.76%)
Apr 29, 2026, 12:49 PM AEST
ASX:NSB Market Cap
ASX:NSB has a market cap or net worth of 34.92 million as of April 29, 2026. Its market cap has increased by 552.67% in one year.
Market Cap
34.92M
Enterprise Value
28.56M
Revenue
317.91K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since July 27, 2018, ASX:NSB's market cap has increased from 16.56M to 34.92M, an increase of 110.93%. That is a compound annual growth rate of 10.10%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avecho Biotechnology | 40.41M |
| EZZ Life Science Holdings | 35.54M |
| Imugene | 44.63M |
| Proteomics International Laboratories | 46.25M |
| Entropy Neurodynamics | 53.85M |
| Prescient Therapeutics | 56.78M |
| Noxopharm | 23.35M |
| Neurizon Therapeutics | 63.08M |